Travaux scientifiques
Uzm. Dr. Serkan Gülcü
12 publications. La source de l’information est indiquée à côté de chaque publication.
-
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Current Oncology, 2026
DOI 10.3390/curroncol33060365 PMID 42346265 Texte intégral en libre accèsSource : OpenAlex
-
Prognostic Impact of Clinicopathological and Inflammatory Markers in Surgically Treated Pulmonary Invasive Mucinous Adenocarcinoma
Seminars in Thoracic and Cardiovascular Surgery, 2026
DOI 10.1053/j.semtcvs.2025.08.007 PMID 40975455 Source : ORCID
-
Baseline vitamin D levels and progression-free survival in patients with HR+/HER2-metastatic breast cancer treated with ribociclib: a retrospective single-center analysis
Discover Oncology, 2026
DOI 10.1007/s12672-026-05502-2 PMID 42340556 Texte intégral en libre accèsSource : ORCID
-
Investigation of systemic treatment responses and prognostic factors in metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)
Journal of Health Sciences and Medicine, 2025
DOI 10.32322/jhsm.1744286 Texte intégral en libre accèsSource : ORCID
-
Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases
Acta haematologica oncologica Turcica., 2025
DOI 10.4274/ahot.galenos.2025.2025-5-4 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Vitamin D Deficiency Predicts Poor Survival in CDK4/6 Inhibitor Treated HR+/HER2− Metastatic Breast Cancer
SSRN Electronic Journal, 2025
DOI 10.2139/ssrn.5600973 Texte intégral en libre accèsSource : OpenAlex
-
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
Akademisyen Kitabevi eBooks, 2024
DOI 10.37609/akya.2380 Texte intégral en libre accèsSource : OpenAlex
-
Garcinol (Garcinia Cambogia)
Akademisyen Kitabevi eBooks, 2024
DOI 10.37609/akya.2380.c13895 Source : ORCID
-
Clinicopathological and Demographics Analysis of Testicular Tumors: A Single-center Experience
Acta haematologica oncologica Turcica., 2024
DOI 10.4274/ahot.galenos.2024.95666 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Anti-Neoplastik İlaçlar
Akademisyen Kitabevi eBooks, 2023
DOI 10.37609/akya.2429 Texte intégral en libre accèsSource : ORCID
-
Evaluation of Relapse Risk Factors and Treatment Outcomes in Stage 1 Germ Cell Testicular Tumors
Dicle Medical Journal / Dicle Tip Dergisi, 2023
DOI 10.5798/dicletip.1411488 Texte intégral en libre accèsSource : OpenAlex
-
Kronik Böbrek Hastalarının Geriatrik Nütrisyonel Risk İndeksi İle Değerlendirilmesi
Batı Karadeniz Tıp Dergisi, 2022
DOI 10.29058/mjwbs.1160225 Texte intégral en libre accèsSource : ORCID